Editas Medicine Inc EDIT
News
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Editas Medicine to Participate in Upcoming Investor Conferences
